Hepatic Progenitor Cells in Human Liver Tumor Development

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2006 Oct 31

PMID 17072946

Citations 21

Authors

Louis Libbrecht

Affiliations

Soon will be listed here.

Abstract

In recent years, the results of several studies suggest that human liver tumors can be derived from hepatic progenitor cells rather than from mature cell types. The available data indeed strongly suggest that most combined hepatocellular-cholangiocarcinomas arise from hepatic progenitor cells that retained their potential to differentiate into the hepatocytic and biliary lineages. Hepatic progenitor cells could also be the basis for some hepatocellular carcinomas and hepatocellular adenomas, although it is very difficult to determine the origin of an individual hepatocellular carcinoma. There is currently not enough data to make statements regarding a hepatic progenitor cell origin of cholangiocarcinoma. The presence of hepatic progenitor cell markers and the presence and extent of the cholangiocellular component are factors that are related to the prognosis of hepatocellular carcinomas and combined hepatocellular-cholangiocarcinomas, respectively.

Citing Articles

Intrahepatic Cholangiocarcinoma Cells Promote Epithelial-mesenchymal Transition of Hepatocellular Carcinoma Cells by Secreting LAMC2.

Cen W, Li J, Tong C, Zhang W, Zhao Y, Lu B J Cancer. 2021; 12(12):3448-3457.

PMID: 33995623 PMC: 8120174. DOI: 10.7150/jca.55627.

Liver progenitor cell-driven liver regeneration.

So J, Kim A, Lee S, Shin D Exp Mol Med. 2020; 52(8):1230-1238.

PMID: 32796957 PMC: 8080804. DOI: 10.1038/s12276-020-0483-0.

Combined hepatocellular-cholangiocarcinoma: An analysis of clinicopathological characteristics after surgery.

Zhang H, Yu X, Xu J, Li J, Zhou Y Medicine (Baltimore). 2019; 98(38):e17102.

PMID: 31567946 PMC: 6756736. DOI: 10.1097/MD.0000000000017102.

New Perspectives in Liver Transplantation: From Regeneration to Bioengineering.

Bizzaro D, Russo F, Burra P Bioengineering (Basel). 2019; 6(3).

PMID: 31514475 PMC: 6783848. DOI: 10.3390/bioengineering6030081.

Human Liver Regeneration: An Etiology Dependent Process.

Van Haele M, Snoeck J, Roskams T Int J Mol Sci. 2019; 20(9).

PMID: 31083462 PMC: 6539121. DOI: 10.3390/ijms20092332.

References

Eleazar J, Memeo L, Jhang J, Mansukhani M, Chin S, Park S . Progenitor cell expansion: an important source of hepatocyte regeneration in chronic hepatitis. J Hepatol. 2004; 41(6):983-91. DOI: 10.1016/j.jhep.2004.08.017. View

Wu P, Fang J, Lau V, Lai C, Lo C, Lau J . Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol. 1996; 149(4):1167-75. PMC: 1865193. View

Libbrecht L, Desmet V, Roskams T . Preneoplastic lesions in human hepatocarcinogenesis. Liver Int. 2005; 25(1):16-27. DOI: 10.1111/j.1478-3231.2005.01016.x. View

Aishima S, Kuroda Y, Asayama Y, Taguchi K, Nishihara Y, Taketomi A . Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma. Hum Pathol. 2006; 37(3):283-91. DOI: 10.1016/j.humpath.2005.08.019. View

Tan J, Hytiroglou P, Wieczorek R, Park Y, Thung S, Arias B . Immunohistochemical evidence for hepatic progenitor cells in liver diseases. Liver. 2002; 22(5):365-73. DOI: 10.1034/j.1600-0676.2002.01622.x. View

Haratake J, Hashimoto H . An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma. Liver. 1995; 15(1):9-15. DOI: 10.1111/j.1600-0676.1995.tb00099.x. View

Lee J, RIM H, Sell S . Heterogeneity of the "oval-cell" response in the hamster liver during cholangiocarcinogenesis following Clonorchis sinensis infection and dimethylnitrosamine treatment. J Hepatol. 1997; 26(6):1313-23. DOI: 10.1016/s0168-8278(97)80467-9. View

Goodman Z, Ishak K, Langloss J, Sesterhenn I, Rabin L . Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer. 1985; 55(1):124-35. DOI: 10.1002/1097-0142(19850101)55:1<124::aid-cncr2820550120>3.0.co;2-z. View

Alison M, Lovell M . Liver cancer: the role of stem cells. Cell Prolif. 2005; 38(6):407-21. PMC: 6496116. DOI: 10.1111/j.1365-2184.2005.00354.x. View

10.

Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J . The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology. 2006; 49(2):138-51. DOI: 10.1111/j.1365-2559.2006.02468.x. View

11.

Chang J, Hilsenbeck S, Fuqua S . Genomic approaches in the management and treatment of breast cancer. Br J Cancer. 2005; 92(4):618-24. PMC: 2361866. DOI: 10.1038/sj.bjc.6602410. View

12.

Dumble M, Croager E, Yeoh G, Quail E . Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma. Carcinogenesis. 2002; 23(3):435-45. DOI: 10.1093/carcin/23.3.435. View

13.

Yano Y, Yamamoto J, Kosuge T, Sakamoto Y, Yamasaki S, Shimada K . Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol. 2003; 33(6):283-7. DOI: 10.1093/jjco/hyg056. View

14.

Libbrecht L, Desmet V, Van Damme B, Roskams T . The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J Hepatol. 2000; 33(1):76-84. DOI: 10.1016/s0168-8278(00)80162-2. View

15.

Guzman G, Alagiozian-Angelova V, Layden-Almer J, Layden T, Testa G, Benedetti E . p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients. Mod Pathol. 2005; 18(11):1498-503. DOI: 10.1038/modpathol.3800458. View

16.

Van Eyken P, Sciot R, Paterson A, Callea F, Kew M, Desmet V . Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. Hum Pathol. 1988; 19(5):562-8. DOI: 10.1016/s0046-8177(88)80205-3. View

17.

Yoon D, Jeong J, Park Y, Kim K, Kwon S, Chi H . Expression of biliary antigen and its clinical significance in hepatocellular carcinoma. Yonsei Med J. 1999; 40(5):472-7. DOI: 10.3349/ymj.1999.40.5.472. View

18.

Hsia C, Thorgeirsson S, Tabor E . Expression of hepatitis B surface and core antigens and transforming growth factor-alpha in "oval cells" of the liver in patients with hepatocellular carcinoma. J Med Virol. 1994; 43(3):216-21. DOI: 10.1002/jmv.1890430304. View

19.

Fiorentino M, Altimari A, Ravaioli M, Gruppioni E, Gabusi E, Corti B . Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation. Clin Cancer Res. 2004; 10(5):1789-95. DOI: 10.1158/1078-0432.ccr-1149-3. View

20.

Libbrecht L, Roskams T . Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol. 2002; 13(6):389-96. DOI: 10.1016/s1084952102001258. View